Stock Events

Stock Events

Cullinan Therapeutics (CGEM) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.99

-0.84

-0.69

-0.54

Details

Expected EPS

-0.787929

Actual EPS

-0.69

Surprise EPS

0.1

Surprise Percent

+12.43%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -0.69 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.